Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD.

Ouellette DR, Lavoie KL.

Int J Chron Obstruct Pulmon Dis. 2017 Feb 16;12:639-650. doi: 10.2147/COPD.S123994. eCollection 2017. Review.

2.

Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression.

Deb A, Sambamoorthi U.

Curr Med Res Opin. 2017 Feb;33(2):201-208. doi: 10.1080/03007995.2016.1248383. Epub 2016 Nov 11.

PMID:
27733085
3.

Two Behavioral Interventions for Patients with Major Depression and Severe COPD.

Alexopoulos GS, Sirey JA, Banerjee S, Kiosses DN, Pollari C, Novitch RS, Artis A, Raue PJ.

Am J Geriatr Psychiatry. 2016 Nov;24(11):964-974. doi: 10.1016/j.jagp.2016.07.014. Epub 2016 Jul 20.

PMID:
27591157
4.

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N.

Neuropsychiatr Dis Treat. 2016 Feb 9;12:297-328. doi: 10.2147/NDT.S79354. eCollection 2016. Review.

5.

Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.

Singh G, Zhang W, Kuo YF, Sharma G.

Chest. 2016 Apr;149(4):905-15. doi: 10.1378/chest.15-0449. Epub 2016 Jan 12.

6.

Anxiety and depression-Important psychological comorbidities of COPD.

Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL.

J Thorac Dis. 2014 Nov;6(11):1615-31. doi: 10.3978/j.issn.2072-1439.2014.09.28. Review.

7.

Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease.

Panagioti M, Scott C, Blakemore A, Coventry PA.

Int J Chron Obstruct Pulmon Dis. 2014 Nov 13;9:1289-306. doi: 10.2147/COPD.S72073. eCollection 2014. Review.

8.

Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.

Avari JN, Alexopoulos GS.

Am J Geriatr Psychiatry. 2015 May;23(5):477-87. doi: 10.1016/j.jagp.2014.06.004. Epub 2014 Jun 20.

9.
10.

Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe COPD.

Alexopoulos GS, Kiosses DN, Sirey JA, Kanellopoulos D, Seirup JK, Novitch RS, Ghosh S, Banerjee S, Raue PJ.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1316-24. doi: 10.1016/j.jagp.2013.05.006. Epub 2013 Aug 14.

11.

A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients.

Tselebis A, Bratis D, Pachi A, Moussas G, Ilias I, Harikiopoulou M, Theodorakopoulou E, Dumitru S, Kosmas E, Vgontzas A, Siafakas N, Tzanakis N.

Multidiscip Respir Med. 2013 Jun 22;8(1):41. doi: 10.1186/2049-6958-8-41.

12.

Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.

Sekiduka-Kumano T, Kawayama T, Ito K, Shoji Y, Matsunaga K, Okamoto M, Edakuni N, Imaoka H, Uchimura N, Hoshino T.

BMC Psychiatry. 2013 May 31;13:159. doi: 10.1186/1471-244X-13-159.

13.

Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.

Qian J, Simoni-Wastila L, Langenberg P, Rattinger GB, Zuckerman IH, Lehmann S, Terrin M.

J Am Geriatr Soc. 2013 May;61(5):754-61. doi: 10.1111/jgs.12220. Epub 2013 Apr 25.

14.

Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.

Qian J, Simoni-Wastila L, Rattinger GB, Zuckerman IH, Lehmann S, Wei YJ, Stuart B.

Int J Geriatr Psychiatry. 2014 Jan;29(1):49-57. doi: 10.1002/gps.3968. Epub 2013 Apr 19.

15.

Palliative care for patients with chronic obstructive pulmonary disease: current perspectives.

Choudhuri AH.

Indian J Palliat Care. 2012 Jan;18(1):6-11. doi: 10.4103/0973-1075.97342.

16.

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O'Donnell DE, Maltais F, Mularski RA, Cave AJ, Mayers I, Kennedy V, Oliver TK, Brown C; Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group.

Can Respir J. 2011 Mar-Apr;18(2):69-78. Review.

17.

Mental disorders and quality of life in COPD patients and their spouses.

Kühl K, Schürmann W, Rief W.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):727-36.

18.

Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA; ACCP Workshop Panel on Anxiety and Depression in COPD.

Chest. 2008 Oct;134(4 Suppl):43S-56S. doi: 10.1378/chest.08-0342. Review.

19.

Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease.

Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG.

J Gen Intern Med. 2008 Nov;23(11):1757-62. doi: 10.1007/s11606-008-0749-z. Epub 2008 Aug 9. Erratum in: J Gen Intern Med. 2008 Nov;23(11):1930.

20.

Depression in COPD--management and quality of life considerations.

Stage KB, Middelboe T, Stage TB, Sørensen CH.

Int J Chron Obstruct Pulmon Dis. 2006;1(3):315-20. Review.

Supplemental Content

Support Center